| Franzen, Daniel |
NCT04556942: Improvement of Cardiovascular Function After Bronchoscopic Lung Volume Reduction Using Endobronchial Valves |
|
|
| Recruiting | N/A | 40 | Europe | Flow Mediated Dilation (FMD) measurement, Blood pressure, pulse and blood oxygen saturation measurement, ST George Respiratory Questionnaire, Physical activity level (PAL) measurement, Withdrawal of a blood sample, Immediate Bronchoscopic Lung Volume Reduction, Delayed Bronchoscopic Lung Volume Reduction | Daniel Franzen | Pulmonary Disease, Chronic Obstructive | 04/22 | 04/22 | | |
| Recruiting | N/A | 300 | Europe | Bronchoscopic Thermal Vapor Ablation, BTVA, InterVapor | Uptake Medical Technology, Inc. | Emphysema or COPD | 12/27 | 12/30 | | |
| Leo, Cornelia |
| Recruiting | 3 | 400 | Europe | Palbociclib 125mg, Ibrance, PD-0332991, Standard endocrine therapy | ETOP IBCSG Partners Foundation, Pfizer | Breast Cancer Recurrent | 01/25 | 11/27 | | |
PREcoopERA, NCT05896566: A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer |
|
|
| Recruiting | 2 | 220 | Europe | Giredestrant, Triptorelin, Anastrozole | ETOP IBCSG Partners Foundation, Hoffmann-La Roche | Breast Cancer | 06/26 | 06/26 | | |
Decrescendo, NCT04675827: De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade |
|
|
| Terminated | 2 | 139 | Europe, RoW | Pertuzumab and tratuzumab fixed dose combination, Adjuvant pertuzumab + trastuzumab FDC SC for 14 cycles, Fixed-dose combination of Perjeta and Herceptin for subcutaneous injection for 14 cycles, Trastuzumab emtansine, Adjuvant T-DM1 | Jules Bordet Institute, Breast International Group, Hoffmann-La Roche, International Drug Development Institute, Institut Curie | HER2-positive Breast Cancer, ER-Negative Breast Cancer, PR-Negative Breast Cancer, Node-negative Breast Cancer | 11/24 | 11/24 | | |
NCT05173415: Marker Technique Comparison in Targeted Axillary Dissection |
|
|
| Recruiting | N/A | 40 | Europe | Sirius Pintution, HydroMARK (C) Clip | Constanze Elfgen | Breast Cancer | 01/25 | 01/25 | | |
VISION I, NCT04289935: Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surrogate for Patient Response to Neoadjuvant Chemotherapy for Breast Cancer |
|
|
| Recruiting | N/A | 420 | Europe, RoW | Vacuum assisted biopsy (VAB) | Klinik Hirslanden, Zurich, Oncoplastic Breast Consortium (OPBC) | Breast Cancer | 06/25 | 06/25 | | |
TAXIS, NCT03513614: Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer |
|
|
| Recruiting | N/A | 1500 | Europe, Canada, US, RoW | Tailored axillary surgery - both Arms, Radiotherapy - Arm A, Radiotherapy - Arm B | University Hospital, Basel, Switzerland, ETOP IBCSG Partners Foundation, Austrian Breast Cancer Study Group | Node-positive Breast Cancer | 12/29 | 12/36 | | |
| Schwedler, Katrin |
| Recruiting | N/A | 300 | Europe | Bronchoscopic Thermal Vapor Ablation, BTVA, InterVapor | Uptake Medical Technology, Inc. | Emphysema or COPD | 12/27 | 12/30 | | |
| Frauchiger-Heuer, Heike |
VISION I, NCT04289935: Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surrogate for Patient Response to Neoadjuvant Chemotherapy for Breast Cancer |
|
|
| Recruiting | N/A | 420 | Europe, RoW | Vacuum assisted biopsy (VAB) | Klinik Hirslanden, Zurich, Oncoplastic Breast Consortium (OPBC) | Breast Cancer | 06/25 | 06/25 | | |
NCT03463954: Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors |
|
|
| Recruiting | N/A | 122 | Europe, US | Novilase Laser ablation | Novian Health Inc. | Malignant Neoplasm of Breast | 09/25 | 09/25 | | |
| Recruiting | N/A | 455 | Europe | quality-of-life questionnaire: BREAST-Q | Thurgau Breast Center | Breast Cancer Female | 12/25 | 06/26 | | |
TAXIS, NCT03513614: Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer |
|
|
| Recruiting | N/A | 1500 | Europe, Canada, US, RoW | Tailored axillary surgery - both Arms, Radiotherapy - Arm A, Radiotherapy - Arm B | University Hospital, Basel, Switzerland, ETOP IBCSG Partners Foundation, Austrian Breast Cancer Study Group | Node-positive Breast Cancer | 12/29 | 12/36 | | |
| Mueller, Dieter Johann |
TAXIS, NCT03513614: Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer |
|
|
| Recruiting | N/A | 1500 | Europe, Canada, US, RoW | Tailored axillary surgery - both Arms, Radiotherapy - Arm A, Radiotherapy - Arm B | University Hospital, Basel, Switzerland, ETOP IBCSG Partners Foundation, Austrian Breast Cancer Study Group | Node-positive Breast Cancer | 12/29 | 12/36 | | |
| Bodmer, Christa |
| Completed | N/A | 102 | Europe, RoW | AeriSeal, Zephyr Valves, Bronchoscopic Lung Volume Reduction (BLVR), Zephyr System | Pulmonx Corporation | Emphysema, COPD, Severe Emphysema | 10/23 | 10/24 | | |
| Recruiting | N/A | 300 | Europe | Bronchoscopic Thermal Vapor Ablation, BTVA, InterVapor | Uptake Medical Technology, Inc. | Emphysema or COPD | 12/27 | 12/30 | | |
